Marta Salido

4.8k total citations · 1 hit paper
111 papers, 2.5k citations indexed

About

Marta Salido is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Marta Salido has authored 111 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Oncology, 37 papers in Pulmonary and Respiratory Medicine and 30 papers in Pathology and Forensic Medicine. Recurrent topics in Marta Salido's work include Lung Cancer Treatments and Mutations (27 papers), Chronic Lymphocytic Leukemia Research (25 papers) and Lymphoma Diagnosis and Treatment (23 papers). Marta Salido is often cited by papers focused on Lung Cancer Treatments and Mutations (27 papers), Chronic Lymphocytic Leukemia Research (25 papers) and Lymphoma Diagnosis and Treatment (23 papers). Marta Salido collaborates with scholars based in Spain, United States and United Kingdom. Marta Salido's co-authors include Françesc Solé, Blanca Espinet, Joan Albanell, Beatríz Bellosillo, Sergi Serrano, Lara Pijuán, Ana Rovira, Edurne Arriola, Sérgio Serrano and Lourdes Florensa and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Marta Salido

108 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a mutation in the extracellular domain of the Epidermal Growth Factor Receptor conferring cetuximab resistance in colorectal cancer

2012 367 citations Alba Dalmases, Beatríz Bellosillo et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marta Salido Spain	27	1.3k	758	709	683	594	111	2.5k
Antonio Frassoldati Italy	27	1.7k 1.4×	689 0.9×	705 1.0×	876 1.3×	302 0.5×	156	2.8k
Alison M. Schram United States	25	1.1k 0.8×	862 1.1×	1.1k 1.5×	783 1.1×	349 0.6×	100	2.9k
Lorenza Pecciarini Italy	17	860 0.7×	356 0.5×	836 1.2×	349 0.5×	507 0.9×	42	2.1k
Sherri Z. Millis United States	25	1.1k 0.9×	852 1.1×	772 1.1×	421 0.6×	360 0.6×	93	2.3k
Roberta Bertorelle Italy	27	771 0.6×	677 0.9×	810 1.1×	537 0.8×	373 0.6×	93	2.8k
Emanuela Bonoldi Italy	23	738 0.6×	292 0.4×	801 1.1×	499 0.7×	341 0.6×	80	1.9k
Bedia A. Barkoh United States	25	667 0.5×	611 0.8×	1.1k 1.6×	1.2k 1.8×	451 0.8×	45	2.4k
Patricia T. Greipp United States	27	631 0.5×	415 0.5×	901 1.3×	247 0.4×	407 0.7×	142	2.4k
Giuseppe Badalamenti Italy	25	1.0k 0.8×	764 1.0×	621 0.9×	553 0.8×	212 0.4×	144	2.3k
Ashish M. Ingle United States	24	788 0.6×	673 0.9×	1.2k 1.7×	348 0.5×	354 0.6×	36	2.5k

Countries citing papers authored by Marta Salido

Since Specialization

Citations

This map shows the geographic impact of Marta Salido's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Salido with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Salido more than expected).

Fields of papers citing papers by Marta Salido

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Salido. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Salido. The network helps show where Marta Salido may publish in the future.

Co-authorship network of co-authors of Marta Salido

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Salido. A scholar is included among the top collaborators of Marta Salido based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Salido. Marta Salido is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sánchez‐González, Blanca, Carmen Lome‐Maldonado, José Yélamos, et al.. (2024). Chromogenic LMO2 mRNA ISH Expression Correlates with LMO2 Protein and Gene Expression and Captures Their Survival Impact in Diffuse Large B-Cell Lymphoma, NOS. Cancers. 16(13). 2378–2378.

Vidal, Joana, et al.. (2022). YAP1-NUTM1 Gene Fusion in Eccrine Porocarcinoma with Late Metastatic Recurrence: A Case Report. Acta Dermato Venereologica. 102. adv00752–adv00752. 3 indexed citations

Vázquez, Ivonne, Anna Puiggros, Blanca Sánchez‐González, et al.. (2021). Lack of expression of LMO2 clone SP51 identifies MYC rearrangements in aggressive large B-cell lymphomas. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 479(6). 1073–1078. 2 indexed citations

Taus, Álvaro, Pedro Rocha, Ainhoa Hernández, et al.. (2020). Plasmatic KRAS Kinetics for the Prediction of Treatment Response and Progression in Patients With KRAS-mutant Lung Adenocarcinoma. Archivos de Bronconeumología. 57(5). 323–329. 2 indexed citations

Clavé, Sergi, Lara Pijuán, Marta Lorenzo, et al.. (2019). Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non–small-cell Lung Cancer: Implications of FISH-positive Patterns. Clinical Lung Cancer. 20(4). e421–e429. 33 indexed citations

Clavé, Sergi, Beatríz Bellosillo, Marta Salido, et al.. (2019). P2.09-34 Next-Generation Sequencing Implementation in Non-Small Cell Lung Cancer Molecular Diagnosis. Journal of Thoracic Oncology. 14(10). S783–S783. 1 indexed citations

Clavé, Sergi, Alba Dalmases, Raquel Longarón, et al.. (2017). P1.02-048 MET Exon 14 Skipping Mutations and Gene Amplifications Are Not Simultaneous Events in NSCLC. Journal of Thoracic Oncology. 12(1). S516–S517. 1 indexed citations

Clavé, Sergi, David Casadevall, Lara Pijuán, et al.. (2016). 4P Co-amplifications of PD-L1/PD-L2 genes (9p24.1) and PD-L1 protein expression in NSCLC patients. Journal of Thoracic Oncology. 11(4). S58–S58. 2 indexed citations

Cañadas, Israel, Federico Rojo, Álvaro Taus, et al.. (2013). Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer. Clinical Cancer Research. 20(4). 938–950. 107 indexed citations

10.

Sánchez‐Rovira, Pedro, Marta Salido, José L. García-Puche, et al.. (2012). Biomarkers characterization of circulating tumour cells in breast cancer patients. Breast Cancer Research. 14(3). R71–R71. 79 indexed citations

11.

Salgado, Rocío, Fernando Gallardo, Octavio Servitje, et al.. (2011). Absence of TCR loci chromosomal translocations in cutaneous T-cell lymphomas. Cancer Genetics. 204(7). 405–409. 6 indexed citations

12.

Muga, Silvia de, Sílvia Hernández, Laia Agell, et al.. (2010). Molecular alterations of EGFR and PTEN in prostate cancer: association with high-grade and advanced-stage carcinomas. Modern Pathology. 23(5). 703–712. 54 indexed citations

13.

Alameda, Francesc, Blanca Espinet, Raquel Muñoz, et al.. (2009). 3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases. Human Pathology. 40(10). 1474–1478. 27 indexed citations

14.

Égervári, Kristóf, Marta Salido, Federico Rojo, et al.. (2009). FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors. Breast Cancer Research. 11(2). 402–402. 23 indexed citations

15.

Baró, Cristina, Marta Salido, Blanca Espinet, et al.. (2007). New chromosomal alterations in a series of 23 splenic marginal zone lymphoma patients revealed by Spectral Karyotyping (SKY). Leukemia Research. 32(5). 727–736. 11 indexed citations

16.

Pajares, I. López, Olaya Villa, Marta Salido, et al.. (2006). Euchromatic variant 16p+. Implications in prenatal diagnosis. Prenatal Diagnosis. 26(6). 535–538. 15 indexed citations

17.

Lloveras, Elisabet, Cynthia Pérez, Françesc Solé, et al.. (2003). Two cases of tetrasomy 9p syndrome with tissue limited mosaicism. American Journal of Medical Genetics Part A. 124A(4). 402–406. 17 indexed citations

18.

Cigudosa, Juan C., María D. Odero, Marı́a José Calasanz, et al.. (2003). De novo erythroleukemia chromosome features include multiple rearrangements, with special involvement of chromosomes 11 and 19. Genes Chromosomes and Cancer. 36(4). 406–412. 29 indexed citations

19.

Espinet, Blanca, Marta Salido, Lourdes Florensa, et al.. (2002). Genetic characterization of the paraimmunoblastic variant of small lymphocytic lymphoma/chronic lymphocytic leukemia: A case report and review of the literature. Human Pathology. 33(11). 1145–1148. 4 indexed citations

20.

Solé, Françesc, Blanca Espinet, Marta Salido, et al.. (2002). A new case of acute nonlymphocytic leukemia (French–American–British subtype M1) with double minutes and c-MYC amplification. Cancer Genetics and Cytogenetics. 132(2). 161–164. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact